Matthew Burge
Royal Brisbane Hospital, NSW, Australia
Presentations this author is a contributor to:
Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (LCCRT) for metropolitan versus rural patients referred to a Queensland tertiary referral hospital (#257)
3:00 PM
Hayden Christie
Poster discussion 1
Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (LCCRT) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospital (#369)
3:00 PM
Hayden Christie
Poster discussion 2
Cetuximab use in metastatic colorectal cancer at five large Queensland public hospitals: comparison to key clinical trials (#277)
3:00 PM
Daniel McKavanagh
Poster discussion 1
Is bevacizumab in metastatic colorectal cancer effectiveness comparable to key Pharmaceutical Benefits Scheme submission clinical trials? Usage results from five large Queensland public hospitals (#394)
3:00 PM
Daniel McKavanagh
Poster discussion 2
Assessment of long course chemoradiotherapy (LCCRT) in regards to completion of chemotherapy. The experience of a tertiary referral hospital (#370)
3:00 PM
Hayden Christie
Poster discussion 2
Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (LCCRT). An assessment at a tertiary referral hospital (#371)
3:00 PM
Hayden Christie
Poster discussion 2
Locally advanced and metastatic pancreatic cancer: An assessment of the provision of chemotherapy at a tertiary referral hospital (#372)
3:00 PM
Hayden Christie
Poster discussion 2
Rural oncology care via teleoncology and outreach clinics: patient and staff perspectives and comparisons. (#293)
3:00 PM
Holly Wyeth
Poster discussion 1